Are you Dr. Ganesan?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 2 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1400 Holcombe Blvd
Inv Cancer Therapeutics, Md Anderson Cancer Center
Houston, TX 77030Phone+1 713-563-8965Fax+1 713-792-5553- Is this information wrong?
Clinical Trials
- Use of Interim PET Scan to Modify Therapy in Advanced Hodgkin's Lymphoma in Order to Improve Outcomes Start of enrollment: 2011 Jan 01
Publications & Presentations
PubMed
- 27 citationsTriple-Negative Breast Cancer Patients Treated at MD Anderson Cancer Center in Phase I Trials: Improved Outcomes with Combination Chemotherapy and Targeted AgentsPrasanth Ganesan, Stacy L. Moulder, J. Jack Lee, Filip Janku, Vicente Valero
Molecular Cancer Therapeutics. 2014-09-24 - 11 citationsEpidermal Growth Factor Receptor P753S Mutation in Cutaneous Squamous Cell Carcinoma Responsive to Cetuximab-Based TherapyPrasanth Ganesan, Siraj M. Ali, Kai Wang, George R. Blumenschein, Bita Esmaeli
Journal of Clinical Oncology. 2016-02-10 - 148 citationsNonadherence to Imatinib adversely affects event free survival in chronic phase chronic myeloid leukemiaPrasanth Ganesan, Tenali Gnana Sagar, Biswajit Dubashi, Rejiv Rajendranath, Krishnarathinam Kannan
American Journal of Hematology. 2011-06-01
Press Mentions
Prasanth Ganesan, MD, DM, on Olanzapine for Whetting the Appetite During ChemotherapyJune 28th, 2023
